Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Belatacept 4-week vs 8-week dosing in kidney transplant
NCT02560558Phase 4Completed
- Sponsor
- Emory University
- Start
- Sep 2015
- Primary completion
- Aug 2019
- Modality
- Fc-Fusion Proteins
- Countries
- 1
01
Overview
A Phase 4 trial of belatacept in kidney transplantation, sponsored by Emory University. Started Sep 2015; status: completed.
02
Drugs
belatacept
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT02560558.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02560558.